SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-126841
Filing Date
2023-04-28
Accepted
2023-04-28 16:00:50
Documents
4
Period of Report
2023-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d420657ddef14a.htm DEF 14A 328448
2 GRAPHIC g420657g11a01.jpg GRAPHIC 172405
3 GRAPHIC g420657g11a02.jpg GRAPHIC 83691
4 GRAPHIC g420657g81k15.jpg GRAPHIC 55398
  Complete submission text file 0001193125-23-126841.txt   743075
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39634 | Film No.: 23865689
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences